Milestone Scientific (MLSS) Equity Ratio (2010 - 2026)

Milestone Scientific has disclosed Equity Ratio across 17 years of filings, most recently posting 0.29 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.29, down 41.56% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.29 (down 41.56% YoY), and the FY2025 annual result was 0.36, down 39.48% from the prior year.
• Equity Ratio came in at 0.29 for Q1 2026 at Milestone Scientific, down from 0.36 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.93 in Q2 2022 to a low of 0.29 in Q1 2026.
• The 5-year median for Equity Ratio is 0.66 (2024), against an average of 0.61.
• Across the five-year window, Equity Ratio rose 10.89% in 2022 and plunged 53.51% in 2025, its largest moves.
• Milestone Scientific's Equity Ratio stood at 0.73 in 2022, then fell by 3.52% to 0.7 in 2023, then fell by 15.51% to 0.6 in 2024, then tumbled by 39.48% to 0.36 in 2025, then decreased by 20.36% to 0.29 in 2026.
• The last three Equity Ratio figures came in at 0.29 (Q1 2026), 0.36 (Q4 2025), and 0.3 (Q3 2025), per Business Quant data.